Simonsz HJ, Carlton J, Griffiths HJ, Horwood AM, Uhlen I, Fronius M, Qirjazi B, Rajka D, Vladutiu C & Hoeve H (2018) Cost‐effectiveness comparison of childhood vision and hearing screening programmes throughout Europe (EUSCREEN Study). Acta Ophthalmologica, 96(12), 3-49.
Carlton J & Auld R (2011) What is vision screening? And more importantly, what is it not?. British and Irish Orthoptic Journal, 8, 71-73.
Carlton J (2011) Clinicians’ perspectives of health related quality of life (HRQoL) implications of amblyopia: a qualitative study. British and Irish Orthoptic Journal, 8, 18-23. View this article in WRRO
Rowen D, Carlton J, Brazier J, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) Comment on FDA guidance for patient-reported outcome. BMJ, 340, 2921-2921.
Carlton J & Czoski-Murray C (2009) Screening for amblyopia and strabismus in children aged 4-5 years: where do we go from here?. British and Irish Orthoptic Journal, 6, 15-21. View this article in WRRO
Carlton J, Karnon J, Czoski-Murray C, Smith KJ & Marr J (2008) The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation.. Health Technol Assess, 12(25), iii-194.
Carlton J & Smith KJ () Screening for amblyopia: a contentious issue. Journal of Pediatric Ophthalmology and Strabismus.
Rowen D, Carlton J & Elliott J () PROM validation using paper-based or online surveys: Data collection methods affect the sociodemographic and health profile of the sample. Value in Health. View this article in WRRO
Carlton J, Barnes S & Haywood A () Patient perspectives in geographic atrophy (GA): exploratory qualitative research to understand the impact of GA for patients and their families. British and Irish Orthoptic Journal. View this article in WRRO
Carlton J (2014) Activities of Daily Vision Scale, Encyclopedia of Quality of Life and Well-Being Research (pp. 20-22). Springer Netherlands
O’Sullivan E, Senécal S, Duhaime G, Lévesque S, Harniss M, Piedmont RL, Maltby H, Hoskins B, Carver CS, Kim S , Carlton J et al (2014) Abandonment, Encyclopedia of Quality of Life and Well-Being Research (pp. 1-1).
Carlton J, Peasgood T, Khan S, Barber R, Bostock J & Keetharuth AD (2019) Optimising patient and public involvement in Patient Reported Outcome Measure (PROM) development. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S38-S39)
Carlton J, Powell P, Woods HB & Mazzone P (2019) Measuring quality of life in Duchenne muscular dystrophy (DMD): a systematic review of content and structural validity using COSMIN. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S145-S145)
Blome C, Carlton J, Heesen C, Janssen MF, Lloyd A, Otten M, Sommer R & Brazier J (2019) How to capture fluctuating health impairments in people with multiple sclerosis: development of an intensive longitudinal assessment of the EQ-5D-5L. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S164-S164)
Powell P & Carlton J (2019) "Social interaction (...) without that then I would probably be miserable'': Understanding quality of life in Duchenne muscular dystrophy. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S109-S109)
Simonsz HJ, Carlton J, Griffith H, Uhlen I, Vladutiu C, Ghititu M, Qirjazi B, Roshi E, Horwood A, Fronius M , Hoeve H et al (2019) EUSCREEN study, stage 1 : data collection on vision and hearing screening programs in 40 European countries and Turkey, Israel, Russia, Malawi, Ruanda, Suth-Africa and India. Investigative Ophthalmology & Visual Science, Vol. 60(9). Vancouver, Canada, 28 April 2019 - 2 May 2019.
Connell J, Carlton J, Peasgood T, Mukuria C, Brazier J, Augustovski F, Belizan M, Engel L, Greiner W, Hanna L , Ludwig K et al (2018) Extending the QALY: developing and testing the proposed items for a new generic measure - results from qualitative review and face validity with patients, social care users and carers. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S189-S189)
Powell P, Carlton J, Rowen D, Uttley L, Buckley-Woods H & Brazier J (2018) Quality of life in Duchenne muscular dystrophy (DMD): initial findings and protocol for a new preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S170-S170)
Carlton J, Rowen D & Elliott J (2018) The new health and self-management in diabetes (HASMID-10) measure: assessing psychometric performance in a large longitudinal survey. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S39-S39)
Simonsz H, Carlton J, Griffith H, Horwood A, Uhlen I, Fronius M, Qirjazi B, Rajka D, Vladutiu C, Hoeve H , Heijnsdijk E et al (2018) Cost-effectiveness comparison of childhood vision and hearing screening programmes throughout Europe (EUSCREEN Study). ACTA OPHTHALMOLOGICA, Vol. 96 (pp 12-12)
Grundy A, Keetharuth A & Carlton J (2017) A critical assessment of service user involvement in designing the ReQoL PROM. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 120-121)
Carlton J, Rowen D & Elliott J (2017) The importance of validation and refinement in PROM development: using the HASMID questionnaire, a measure of self-management in diabetes. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 124-124)
Elliott J, Carlton J, Rowen D & Brazier J (2017) Changing HbA(1c) units: a hindarance, not a help to patients. DIABETOLOGIA, Vol. 60 (pp S342-S342)
Simonsz HJ, Sloot F, Sami A, Vladutiu C, Qirjazi B, Carlton J, Uhlen I, Horwood AM, Fronius M, de Koning H , Hoeve H et al (2017) Start of EUSCREEN Study that compares cost-effectiveness of childhood vision and hearing screening programmes in all European countries and implements these in Romania and Albania. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 58(8) (pp 2361-2361), 7 May 2017 - 11 May 2017. View this article in WRRO
Carlton J, Rowen D, Elliott J, Brazier J, Stevens K, Basarir H & Labeit A (2016) Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14 View this article in WRRO
Keetharuth A, Brazier JE, Connell J, Carlton J, Ricketts T, Buck ET, Barkham M, Bjorner JB, Croudace T & Browne J (2016) Constructing the short recovering quality of life (ReQoL) measure for use in a mental health population: combining psychometric and qualitative evidence. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 70-70)
Connell J, Brazier JE, Carlton J, Buck ET, Grundy A, Keetharuth A, Ricketts T & Barkham M (2016) Developing the recovery of quality of life measure (ReQoL): the views of mental health service users on potential items. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 46-47)
Brazier JE, Keetharuth A, Connell J, Carlton J, Buck ET, Ricketts T & Barkham M (2016) First validation of the short recovering quality of life (ReQoL) measure. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 96-96)
Rowen D, Labeit A, Brazier JE, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H & Meadows K (2016) Valuing the impact of self-management on quality of life in diabetes using discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 134-134)
Carlton J () Cost-effectiveness of screening programmes for amblyopia. World Ophthalmological Congress 2010. Berlin, Germany, 5 June 2010 - 9 June 2010.
Carlton J () Impact of amblyopia on quality of life. World Ophthalmological Congress 2010. Berlin, Germany, 5 June 2010 - 9 June 2010.
Brazier J, Poku E & Carlton J () Does vision matter: a systematic review of the relationship between visual acuity and utilities.. Royal Collage of Ophthalmologists Annual Congress. Liverpool, UK, 25 May 2010 - 27 May 2010.
Carlton J () Challenges encountered in developing PROMs: The experience so far in the creation of a PROM for amblyopia in the paediatric population. Part of Symposium: Going to the PROM? Are patient reported outcome measures (PROMs) a useful tool to measure the impact of nursing interventions?. International Nursing Research Conference. Newcastle, UK, 11 May 2010 - 13 May 2010.
Carlton J () Development of a paediatric disease-specific measure of health related quality of life in amblyopia. British Isles Paediatric Ophthalmology and Strabismus Association (BIPOSA). Glasgow, UK, 23 September 2009 - 25 September 2009.
Carlton J () Quality of life issues in amblyopia.. Rotterdam Amblyopia Meeting. University Medical Centre, Rotterdam, Netherlands, 12 February 2009.
Czoski-Murray C, Carlton C, Young T, Brazier J, Papo N & Kwon Kang H () Health state valuation for ARMD visual impairment states using simulation lenses. 6th iHEA World Congress on Health Economics. Copenhagen, Denmark, July 2007.
Brazier J, Bansback N, Espallargues M, Czoski-Murray C & Phippen G () Are generic preference-based measures truly generic? The case of visual impairment.. 5th iHEA World Congress on Health Economics. Barcelona, Spain, July 2005.
Brazier J, Bansback N, Espallargues M, Czoski-Murray C, Phippen G & Carlton J () The relationship between impairment and generic preference based measures, patient valuations and patient life satisfaction in Age Related Macular Degeneration.. European Conference on Health Economics. London School of Economics, London, 2005.
Carlton J, Phippen G, Hughes L, Czoski-Murray C, Bansback N, Espallargues M, Brand C & Brazier J () A survey of quality of life in patients with age related macular degeneration. Transactions of Xth International Orthoptic Congress. Melbourne, Australia, 14 November 2004 - 17 November 2004.
Carlton J () Lateral gaze incomitance in distance exotropia: should the neutralising prism be placed over the abducting or adducting eye?. British Isles Strabismological Association (BISA). York, UK, 7 October 2004.
Espallargues M, Brazier J, Czoski-Murray C, Bansback N, Phippen G & Carlton J () Health status measurement in Age-Related Macular Disease: new evidence for clinic and economic evaluation. Health Technology Assessment International (HTAi). Krakow, Poland, 30 May 2004 - 2 June 2004.
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Malawi View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Poland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Luxembourg View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Israel View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Iceland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Hungary View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Finland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2019) Summary Vision Screening Data: Austria View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Switzerland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Sweden View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Spain View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Slovenia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Slovakia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Serbia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Scotland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Romania View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Norway View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Northern Ireland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Macedonia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Netherlands View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Moldova View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Malta View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Lithuania View this article in WRRO
Mazzzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Latvia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Kosovo View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Italy View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Republic of Ireland View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Greece View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Germany View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: France View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Faroe Islands View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Estonia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Denmark View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Czech Republic View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Cyprus View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Croatia View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Bulgaria View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Bosnia and Herzegovina View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: Belgium (Brussels) View this article in WRRO
Mazzone P, Griffiths H & Carlton J (2018) Summary Vision Screening Data: Albania View this article in WRRO
Mazzone P, Carlton J & Griffiths H (2018) Summary Vision Screening Data: England & Wales View this article in WRRO
Brazier J, Poku E, Cooper K & Carlton J (2010) Reviewing the impact of visual acuity on utility values and assessing the appropriateness of the EQ-5D in Diabetic Macular Edema
Brazier J, Poku E, Cooper K & Carlton J (2010) Reviewing the impact of visual acuity on utility values and assessing the appropriateness of the EQ-5D in Diabetic Macular Edema. Report to Novartis. April 2010.
Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) FDA on PROMs: Two important points. BMJ (Online), 341(7776), 746.
Carlton J (2010) Clinicians’ perspectives of health related quality of life (HRQoL) implications of amblyopia: a qualitative study. Retrieved from http://eprints.whiterose.ac.uk/11196/
Czoski-Murray C, Carlton J, Brazier J, Kang HK, Young TA & Papo NL (2007) Valuing condition specific health states using simulation contact lenses. Retrieved from http://eprints.whiterose.ac.uk/11028/
Carlton J & Kaltenthaler E (2010) Health Related Quality of Life Measures (HRQoL) in Orthoptics. British and Irish Orthoptic Society Scientific Conference, Oxford UK.
Czoski-Murray C, Carlton J, Brazier J, Young T, Kwon Kang H & Papo N (2007) Visual impairment states: valuation using simulation lenses. International Society for Quality of Life Research, Toronto, Canada.
Powell P, Carlton J, Woods H & Mazzone P (2019) Patient reported outcome measures of quality of life in Duchenne muscular dystrophy (DMD): a systematic review of content and structural validity using COSMIN. HEDS Discussion Paper Series. View this article in WRRO
